Condition
Mesothelioma
Estimated Enrollment: 125
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: IFCT-1501
Study First Received: March 9, 2016
Last Updated: October 24, 2016
Estimated Primary Completion Date: May 2017
Primary Outcome Measures:
Disease Control rate assessed by CT scan|Number of participants with treatment-related adverse events as assessed by CTCAE v4.0|Progression-Free Survival|Overall Survival|Quality of Life|prognosis impact of blood biomarkers (exploratory studies)
Sponsors and Collaborators:
Intergroupe Francophone de Cancerologie Thoracique
Website Link: https://ClinicalTrials.gov/show/NCT02716272
